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Summary 3D echocardiography has been proven to be useful for clarifying compli-
cated cardiac anatomies and hemodynamics. Recently introduced real-time 3D TEE
may overcome technical and quality problems and result in widespread use of 3DEchocardiography;
Heart valve; echocardiography in routine clinical settings.
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ntroduction
D echocardiography is able to provide intuitive
ecognition of cardiac structures from any spatial
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oint of view and may provide complete infor-
ation about absolute heart chamber volumes
nd functions. Although there are still limita-
ions to the currently available 3D ultrasound
ethods due to its relatively low image quality
nd low time resolution, this method would be
ne of the ultimate goals of cardiac imaging. In
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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light of the recent development of real-time 3D
transesophageal echocardiography (TEE), this new
imaging method may become a clinical standard
within a few years [1,2].
In general, there are two major deﬁnite
advantages of 3D imaging over conventional 2D
echocardiography as follows:
(1) Quantiﬁcation of absolute cardiac chamber
volumes, including left ventricle (LV), right ven-
tricle (RV), and left atrial (LA) volumes and
their functions.
(2) Visualization of the 3D structure and dynamic
motion images of the heart, especially heart
valve structures.
Quantiﬁcation of absolute cardiac
chamber volume and function
LV volumes and LV ejection fractions
Absolute LV volumes and their dynamic changes
during cardiac cycles are indispensable and fun-
damental indices for assessing LV function in any
cardiac disease. 3D echocardiographic methods
provide unique capabilities for determining abso-
lute LV volumes, stroke volumes, and ejection
fractions (EF) [3—17]. Magnetic resonance imaging
(MRI) is often employed as an independent gold
standard to validate the accuracy of 3D echocardio-
graphy for determining LV volumes and EF (Fig. 1)
[10,11,13,14,18,19]. Correlations of LV parameters,
including LV volumes and EF, between 3D echocar-
diography and MRI are reportedly excellent (Fig. 1)
[10,11,13,18,19]. However, underestimation of
MRI-derived LV volumes by 3D echocardiography
has been consistently found in these publica-
tions [10,11,13,19]. In a recent clinical study,
3D echocardiography slightly underestimated MRI
derived end-diastolic and end-systolic LV volumes
by 5 and 6ml respectively [13]. In another study,
however, real-time 3D echocardiography underesti-
mated MRI-derived end-diastolic LV volume (mean
168ml) by 15ml while 2D echocardiography under-
estimated MRI derived end-diastolic LV volume
by 57ml [19]. Along with these publications, a
multi-center study showed clinical feasibility of
transthoracic real-time 3D echocardiography for
assessing LV volumes and EF, and the poten-
tial to alter clinical decision-making by this new
method was suggested [17]. For patients with
localized LV wall motion abnormalities, including
aneurysmal LV, conventional 2D methods could not
be used accurately for determining absolute LV
volumes and EF because of unpredictable asym-
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sigure 1 Comparison of LV volume determined by MRI
nd 3D echocardiography.
etricity of the LV geometry [20—23]. Fig. 2
emonstrates normal LV size and function obtained
y transthoracic real-time 3D echocardiography.
niform and harmonious contraction in all 16 or 17
egments are well presented by the 3D echocardio-
raphic imaging. In contrast, Fig. 3 demonstrates
ocalized wall motion abnormality with abnormal
egional stroke volume and EF. In this partic-
lar patient, 3D imaging can visualize akinesis
f the lateral wall and quantify its regional EF
f zero. When the image quality improves with
etter time resolution, such an analysis of local-
zed wall motion by 3D echocardiography may
eveal real efﬁcacy of resynchronization therapy
n patients [24—27]. However, with currently avail-
ble systems, 3D echocardiographic analysis in
schemic cardiomyopathy is not consistent with
issue Doppler imaging for the assessment of LV
yssnchrony [28].
tress echocardiography
tress echocardiography is now widely accepted
n the USA for evaluating patients with coronary
rtery disease (CAD). However, conventional 2D
tress echocardiography requires acquisition of at
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figure 2 A 3D echocardiographic image of a normal left v
nalyzed with color time/volume curve for each LV segm
east four different 2D image planes, including
arasternal long-axis and short-axis, and apical 4-
nd 2-chamber views to analyze all the LV seg-
ental walls. Even with experienced sonographers,
t usually takes about 20—30 s to obtain all four
D images. This may lead to some images being
cquired at submaximal heart rates at presumed
‘peak’’ heart rates. This limitation may reduce the
peciﬁcity and sensitivity of stress echocardiogra-
hy. Real-time 3D echocardiography is reportedly
ble to overcome this limitation by its fast scanning
f all the LV walls [29—32]. Ahmad et al. reported
hat mean scanning time was 27 s by real-time 3D
nd 62 s by 2D echocardiography [30]. In addition,
n 90 patients who had coronary angiography, 3D
chocardiography demonstrated higher sensitivity
f 87% in the detection of CAD compared with 79%
y 2D echocardiography [30]. Simultaneous multi-
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aicle (LV). Note that regional wall motion is quantitatively
lane imaging in 3D space is now possible with a
ewer 3D platform. Thus, it may become realistic to
mploy real-time 3D echocardiography for clinical
tress echocardiography.
valuation of LV mass
ardiovascular mortality and morbidity have been
hown to increase with LV hypertrophy independent
f other cardiovascular risk factors [33]. Increased
V mass also reﬂects the cumulative effects of car-
iovascular risk factors [33]. Therefore, LV mass
s an important and independent index of cardiac
unctional status for patient prognosis. 3D echocar-
iography has been introduced and repeatedly used
o evaluate LV mass [14,34—40]. In a previous
n vitro and clinical study, 3D echocardiography
lightly underestimated LV mass by necropsy and
lso that by MRI (Fig. 4). However, more recently,
172 T. Shiota
Figure 3 A 3D echocardiographic image of left ventricle (LV)
shows the segmental wall motion abnormality in systole. Th
segment and almost no contraction of the lateral wall.
Figure 4 Comparison of LV mass determined by necropsy
and 3D echocardiography (upper panel) and MRI and 3D
echocardiography (lower panel).
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ewith regional wall motion abnormality. The upper panel
e lower panel presents the time-volume curves of each
ouleur et al. reported that 3D echocardiogra-
hy permitted accurate determination of LV mass
rrespective of the presence or absence of wall
otion abnormality. LV parameters, including LV
ass, obtained by 3D echocardiography were also
s reproducible as those obtained by MRI. This
tudy suggested that 3D echocardiography could
e used to follow-up patients with LV hypertrophy
nd/or remodeling [14]. Infarction size is also of
reat interest, and 3D echocardiography is report-
dly accurate to evaluate infracted LV mass [41].
owever, LV mass or infarct size determination by
D echocardiography may not be necessary or indi-
ated in most patients routinely.
V volumes and functionsrom a clinical point of view, there may be rel-
tively less interest about RV volumes and RV
unctions than LV volumes and LV functions. How-
ver, in certain conditions such as those in patients
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figure 5 A 3D echocardiographic image of the right ven-
ricle (RV). Note the unique crescent shape of RV cavity.
V, tricuspid valve; RVOT, right ventricular outﬂow tract.
ith congenital heart diseases and those with cor
ulmonale, and pulmonary embolism, RV functions
an be more important than LV functions. For deter-
ining absolute RV chamber volumes and stroke
olumes, 3D imaging methods are even more impor-
ant than for determining LV volumes because the
V chamber has a complex geometry (Fig. 5). Thus,
uite a few studies were performed with the use
f 3D echocardiography for determining RV vol-
mes, mass, and function [42—46]. In vitro models
ere used to validate 3D echocardiography for
etermining RV volumes [46]. Employing real-time
olumetric images of the RV in an animal model
f RV volume overload, RV stroke volumes were
etermined by the use of parallel slices of the 3D
olume in a previous study [43]. Good correlation
nd agreement were found between RV stroke vol-
mes obtained by electromagnetic ﬂow probes and
t
d
c
t
Figure 6 Comparison of left atrial volume det173
eters and those obtained by the real-time 3D
ethod (r = 0.80) [43]. As for clinical studies, MRI
as used to validate the accuracy of 3D echocardio-
raphy for determining RV size and function in 30
atients (14 with grossly normal cardiac anatomy
nd 16 with major congenital heart disease) [47].
he RVEF was measured with 4% variability for 3D
chocardiography and 5% variability for MRI with
correlation coefﬁcient of r = 0.91. The RV end-
iastolic volume was measured at 71± 15ml with
D echocardiography and at 70± 15ml with MRI
r = 0.99), end-systolic volume measured 40± 10ml
ith 3D echocardiography and 39± 10ml with MRI
r = 0.98) [47]. The correlation and agreement val-
es are better than previously reported values
robably due to improvement of the 3D echocar-
iographic imaging quality and analysis software
42,47]. Such a trend is promising for the future
linical use of 3D echocardiography for quantifying
V volumes and function.
A volumes and functions
he size of the LA is also an important index for
ssessing severity of mitral valve stenosis, mitral
alve regurgitation, and LV stiffness. LA size has
een determined by M-mode or 2D echocardio-
raphy at the present time [4] and appears to
e sufﬁcient for clinical evaluation. Considering
ts complicated anatomical geometry, LA volume
s potentially more accurately assessed by 3D
ethods [48—56]. However, a signiﬁcant underes-
imation of MRI derived LA volumes was reported
48] (Fig. 6). In previous studies, which employed
eal-time 3D echocardiography, LA functions were
ound to be closely related to LV diastolic func-
ions [55,57]. One study demonstrated a dramatic
epression of LA function during proximal left cir-
umﬂex coronary artery occlusion [57]. Considering
he importance of LA booster pump function in
ermined by MRI and 3D echocardiography.
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patients with LV systolic dysfunction, precise and
accurate analysis of LA function is essential for
clinical management. In a recent clinical study, LA
volumes were determined by 3D echocardiography
in 108 patients with severe LV dysfunction and in
sinus rhythm. During follow-up, 31 patients (29%)
showed clinical events, including 3 cardiac deaths
and 28 hospitalizations as a result of heart failure.
Patients with initial LA volume of less than 100ml
had a signiﬁcantly higher 1-year event-free survival
than those with that of greater than or equal to
100ml (80% versus 48%; P < 0.001). Thus, 3D echo
derived LA volume was considered to be a major
predictor of clinical events in patients with severe
left ventricular dysfunction and in sinus rhythm
[56].
3D visualization of cardiac structures
The other important advantage of 3D over conven-
tional 2D echocardiography is virtual visualization
of the anatomy of cardiac structures such as heart
chambers and valves. Rotated and bird’s eye views
would provide unique and critical views of morpho-
logical disorders.
Valvular heart diseases
The mitral valve
Mitral regurgitation. Location of the ﬂail or pro-
lapsed leaﬂet (medial, central, and lateral) and
its geometry are essential information for deter-
mining surgical corrections of mitral regurgitation
(MR). However, conventional 2D echocardiography
requires multiple views of the mitral valve and
mental reconstruction of the 3D image of the dis-
eased structure. Many investigators reported the
usefulness of 3D echocardiography for visualizing,
localizing and quantifying mitral valve abnormali-
p
c
d
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Figure 7 En face 3D views of a normalT. Shiota
ies in patients with MR [2,58—68]. The superiority
f transthoracic real-time 3D echocardiography
ver conventional 2D echo methods was reported
ultiple times in analyzing the anatomy of mitral
alve in patients with MR since the introduction
f transthoracic real-time 3D echocardiography
63,65—68]. Although currently ECG gating is
equired for obtaining the entire mitral valve from
he apex, this 3D method is still much easier to
pply and more consistent and reliable than any
revious volumetric 3D echocardiographic method.
The use of TEE has also been repeatedly reported
o evaluate mitral valve anatomy in patients with
R [2,58,59,62]. In one of the previous studies, TEE
ith 3D reconstruction was used in 91 patients with
evere MR due to mitral valve prolapse, and the
ocation and extent of the prolapse by the recon-
truction 3D echo were compared to the surgical
tatus. The volume of prolapsing leaﬂet was cal-
ulated and compared to the volume of resected
issue whenever a repair was attempted. There was
n excellent correlation between the echocardio-
raphic localization of the prolapse and surgical
nspection, and between the volume of prolapsing
nd surgically resected tissue (r = 0.94, P < 0.0001).
he authors concluded that the 3D reconstruction
cho method allowed a precise localization and an
ccurate quantiﬁcation of the prolapsing portion
f the leaﬂets. Reconstruction TEE 3D echocar-
iography, therefore, can provide reﬁnements in
he surgical planning of mitral valve repair and
n the selection of candidates for this interven-
ion. Regrettably, this valuable method was not
idely used. This can be explained by its technical
ifﬁculties, including suboptimal gating, synchro-
ization due to the motion of patients and the TEE
robe during sequential 2D imaging and also by
umbersome reconstruction techniques. Few car-
iologists could actually obtain satisfactory en face
itral valve images. As far as I know, few car-
mitral valve from the left atrium.
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f the posterior leaﬂet. Left panel in diastole, right pane
iac centers would be able to implement this old
ype 3D TEE method in clinical practice despite its
otential values. However, a recently introduced
ew real-time or Live 3D TEE is to overcome such
imitations [1,2]. Sugeng et al. reported clinical
l
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igure 9 A color Doppler 3D echocardiographic image of se
an be used to estimate the site of the regurgitant oriﬁce an
entricle.ium in a patient with severe prolapse of the mid portion
systole.
se of real-time 3D TEE in 211 patients [2]. Excel-
ent visualization of the mitral valve (85—91% for
ll scallops of both MV leaﬂets), interatrial septum
84%), left atrial appendage (86%), and left ventri-
le (77%) was observed. This new real-time 3D TEE
vere MR. The location of ﬂow convergence and its size
d the severity of regurgitation. LA, left atrium; LV, left
T. Shiota
Figure 10 A Live 3D TEE image before balloon dilation
demonstrates complicated structure of a stenotic mitral
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demonstrated excellent image quality of the mitral
valve and its pathologies (Figs. 7 and 8).
In patients with MR, color Doppler capability,
which has been introduced in both reconstruction
and real-time 3D systems, could provide 3D images
of regurgitant ﬂow jet velocity and ﬂow conver-
gence [69—74]. The location of ﬂow convergence
zone and its size can determine the location of
the regurgitant oriﬁce and severity of MR (Fig. 9).
Color Doppler 3D echocardiography has demon-
strated that the shape of ﬂow convergence zone
is not a hemisphere in many conditions such as for
irregular or asymmetric shaped oriﬁces and also in
patients with functional or ischemic MR [74—77].
Multiple institutions have proposed more realistic
geometric assumptions such as a hemiellipse and a
hemiellipsoid for ﬂow convergence zones to obtain
regurgitant volumes [73,74,78].
Mitral stenosis. In patients with mitral steno-
sis, 3D echocardiography was used to determine
morphological abnormalities and stenotic valve
areas [63,79—84]. In 48 patients with mitral steno-
sis, mitral valve area (MVA) was determined by
planimetry using volumetric real-time 3D echocar-
diography and compared tomeasurements obtained
by 2D echocardiography and Doppler pressure half-
time (PHT). While 2D echocardiography allowed
planimetry of the mitral valve in 43 of 48
patients (89%), calculation of the MVA was pos-
sible in all patients when 3D echocardiography
was used. MVA by 3D echocardiography correlated
well with MVA by 2D echocardiography (r = 0.93,
mean difference, 0.09 cm2) and by PHT (r = 0.87,
mean difference, 0.16 cm2). Interobserver variabil-
ity was signiﬁcantly less for 3D echocardiography
than for 2D echocardiography (SD = 0.08 cm2 versus
SD = 0.23 cm2; P < 0.001). In this study, 3D echocar-
diography reportedly provided accurate and highly
reproducible measurements of MVA and can eas-
ily be performed from an apical approach [80].
In another study, a more recent type of real-
time 3D echocardiographic system was used for
mitral valve planimetry [82]. This was reportedly
more accurate than the Gorlin method to mea-
sure the valve area although the authors used three
classical 2D echo methods (2D planimetry, pres-
sure half-time, and PISA method) as the reference
method. The authors concluded that we should
keep in mind that 3D echo planimetry may be a
better reference method than the Gorlin method
to assess the severity of rheumatic mitral steno-
sis [82]. Recently introduced real-time 3D TEE
demonstrated striking images of mitral stenosis in
patients (Fig. 10). Not only the severity of the
stenosis, but also the shape, location, and anatomi-
cal abnormalities of the mitral valve leaﬂets such as
q
p
v
d
ralve. The deepest (away form the left atrium and close
he left ventricle) portion of the mitral valve is critically
tenotic.
eavy calciﬁcation are visualized in a most intuitive
ay.
pplication of 3D echocardiography on balloon
itral valvuloplasty. Application of 3D echocar-
iography for mitral valvuloplasty (Fig. 11) has
lso been reported multiple times [85—88]. In one
f these studies, old type 3D TEE with electro-
ardiographic and respiratory cycle gated image
cquisition was used in 19 patients undergoing bal-
oon mitral valvuloplasty. The mitral valve was
iewed ‘‘en face’’ as if looking up from the
eft ventricle. The mean MVA (by pressure half-
ime from the Doppler of the two-dimensional
chocardiogram) increased after valvuloplasty from
.86± 0.06 to 2.07± 0.10 cm2; P < 0.0001. This was
imilar to the MVAs obtained by planimetry from
D images. 3D TEE reconstructions showed a com-
lete commissural split in 10 patients and partial
plitting in 9 patients. In 3 of the 8 patients who
ad an increase in the amount of mitral regur-
itation, 3D reconstructions were able to detect
ears within the valve leaﬂet. One leaﬂet tear
ctually extended up to the mitral valve annu-
us and was associated with the only case of
evere MR. The authors concluded that 3D TEE
econstruction enabled visualization of the mitral
alve so that commissural splitting and leaﬂet
ears not seen on 2D echocardiography became
isible [85].
Thanks to recent developments of relatively high
uality transthoracic real-time 3D echocardiogra-
hy, improvement of valve area and changes in
alve geometry after balloon valvuloplasty were
emonstrated in a recent study [86]. Transthoracic
eal-time 3D echo, instead of multiplane TEE 3D
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he many small particles are air bubbles.
econstruction, was employed to measure the valve
rea in 29 patients with rheumatic mitral steno-
is who underwent balloon valvuloplasty [86]. The
uthors also concluded that transthoracic real-time
D echocardiography was a feasible and accu-
ate technique for measuring mitral valve area in
atients with rheumatic mitral valve stenosis [86].
h
a
T
p
igure 12 A 3D reconstruction image of a mitral annulus and
oints and curved leaﬂets lines. Ao, aorta; A, anterior; AL, aning of the procedure through the stenotic mitral valve.
Now naturally, the new real-time 3D TEE is
xpected to show even better results for evalu-
ting the efﬁcacy of mitral valvoplasty due to its
igher resolution of the images of the mitral valve
nd apparatus than the old type reconstruction 3D
EE and transthoracic real-time 3D echocardiogra-
hy (Figs. 10 and 11).
posterior valve prolapse extracted from multiple annular
terolateral; P, posterior; PM, postero-medial.
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3D geometry of the mitral and tricuspid annulus.
Real-time 3D echocardiographic methods have been
used in the evaluation of non-planarity and area
change of mitral annulus in animals and in patients
[89—96]. Extracted 3D images obtained by mul-
tiplane TEE could be used in the evaluation of
non-planarity and area change of the mitral annulus
in patients with an annuloplasty ring [97,98]. The
saddle-shaped geometry of the mitral annulus has
been repeatedly conﬁrmed by 3D echocardiogra-
phy, and 3D echocardiographic assessment of mitral
annular size and function in control subjects and
patients with cardiomyopathy was reportedly accu-
rate and well correlated with MRI [95]. Not only
the annulus geometry, but also valve tethering or
tenting in ischemic cardiomyopathy and idiopathic
cardiomyopathy were quantitatively analyzed by
3D echocardiography [93,94,96,99,100]. Consider-
ing the clinical importance of annuloplasty for
managing patients with MR, such detailed geo-
metric evaluation is to be performed in order to
improve surgical results. Fig. 12 shows a mitral
annulus and valve morphology extracted from mul-
tiple annular points and curved leaﬂet lines. A
non-surgical approach to manage ischemic MR was
introduced recently, and real-time 3D echocardio-
graphy was used to evaluate geometric changes of
the mitral annulus before and after percutaneous
mitral valve repair [92].
Not only the 3D geometry of the mitral annu-
lus, but also that of the tricuspid annulus have
been investigated and reported with the use of 3D
echocardiography [101—103]. Fukuda et al. found
the tricuspid annulus to have a unique geometry
(Fig. 13). With the 3D geometric concept, a new
s
a
t
t
i
Figure 14 Live 3D TEE images of a normal aortic valigure 13 A 3D reconstruction geometry of the tricuspid
nnulus. A, anterior; L, lateral; P, posterior; S, septal.
nnuloplasty ring for the tricuspid annulus was con-
eived, developed and used in patients with severe
ricuspid regurgitation [104]. Short-term results
ith this new annuloplasty ring appeared be satis-
actory [104]. 3D echocardiography is valuable not
nly for understanding complicated cardiac struc-
ures, but also for developing new strategies like
his new annuloplasty ring for treating patients.
he aortic valve. The aortic valve diseases may
rove to be one of the most important applica-
ions of 3D echocardiography [105—108]. In one
f the recent studies with aortic stenosis, 3D
chocardiographic methods for planimetry of the
ortic valve area showed good agreement with
he standard TEE technique in patients with aortic
tenosis [107]. Also 3D planimetry methods were
t least as good as standard TEE and had bet-
er reproducibility [107]. The authors concluded
hat 3D aortic valve planimetry is a novel non-
nvasive technique, which provides an accurate and
ve. Left panel in diastole, right panel in systole.
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pigure 15 A 3D echocardiographic image of hypertrop
ocated anterior mitral leaftlet during systole (arrows). A
eliable quantitative assessment of aortic steno-
is [107]. Also color Doppler 3D echocardiography
as used to evaluate aortic valve area in 68
atients with aortic stenosis (mean age of 74
ears) and in animal models in a recent study. In
xperimentally distorted LV outﬂow tract (LVOT)
eometry in sheep, 3D echocardiography-derived
troke volumes correlated better with ﬂow probe
ssessment (r = 0.96, P < 0.001) than 2D echocardio-
raphy (r = 0.71, P = 0.006). The authors concluded
hat aortic valve area by continuity equation with
he use of color Doppler-derived LVOT stroke vol-
me is more accurate than that by the conventional
D continuity method [108]. However, the image
uality of 3D echocardiography may not be optimal
n all the patients with aortic valve disease. In fact,
ugeng et al. reported a low rate of successful imag-
ng of the aortic valve (only 18%) as opposed to the
itral valve (85—91%) with the use of real-time 3D
EE [2]. Fig. 14 demonstrates ultrasound images of
normal aortic valve obtained by the newly devel-
ped high quality Live 3D TEE. Despite the previous
tudy [2], it is clear that this new imaging method
as the potential for providing detailed informa-
ion on the pathophysiology of a variety of aortic
alve diseases. As for the subaortic membrane,
ultiplane analysis of 3D datasets was reportedly a
ensitive and accurate mode for delineation of mor-
hological details of discrete subaortic stenosis,
dding to information gained from 2D echocardiog-
aphy [109].
f
t
g
aobstructive cardiomyopathy, demonstrating a medially
orta; LA, left atrium; LV, left ventricle.
ypertrophic cardiomyopathy
n patients with hypertrophic cardiomyopathy,
egional wall motion and wall thickness have
een assessed by 3D methods [110]. The decrease
n regional systolic function with increasing LV
ypertrophy was found in both idiopathic and
ypertensive cardiomyopathy [110]. In old recon-
truction 3D TEE and more recent transthoracic
eal-time 3D studies, the smallest LVOT area
uring systole was quantiﬁed by 3D echocardiogra-
hy [111—113]. In 142 patients with hypertrophic
ardiomyopathy, 3D echo-derived LVOT area was
nversely correlated with pressure gradient across
VOT (r = 0.82, P < 0.001) [113]. The value of the
D derived LVOT area less than 0.85 cm2 predicted
evere obstruction [113]. 3D echocardiography pro-
ides not only LVOT area but also morphological
bnormalities of the hypertrophied septum and the
itral valve leaﬂets in patients with hypertrophic
ardiomyopathy [114]. In transthoracic 3D echo
tudies, a medially located systolic anterior motion
as found [112,114]. Fig. 15 shows such a medi-
lly located systolic anterior motion of the mitral
alve. Considering the development of high quality
eal-time TEE versions, 3D echocardiography may
lay an indispensable role in the operating room
or determining the precise location of myectomy in
he future [1,2,115]. In one recent 3D echocardio-
raphic study, complicatedmitral annular geometry
nd dynamics during a cardiac cycle was evalu-
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RFigure 16 A 3D echocardiographic image of an atrial
septal defect (ASD) obtained by Live 3D TEE.
ated in patients with hypertensive hypertrophy and
hypertrophic cardiomyopathy. In this study, annular
function in hypertensive hypertrophy was similar to
that of the normal group while annular apico-basal
motion and area changes were reduced in hyper-
trophic cardiomyopathy [116].
Congenital heart disease
3D echocardiography methods, including 3D TEE,
have been reportedly proven to be a powerful tool
to evaluate congenital heart diseases [117—127].
In one study, real-time transthoracic 3D echocar-
diograpic measurements of maximum dimension,
maximum circumference, and maximum area of
atrial septal defect (ASD) agreed well with the
sizing balloon in the catheterization laboratory
[126]. Real-time or Live 3D TEE can visualize an
ASD with better imaging quality than transtho-
racic 3D echocardiography (Fig. 16). Applications
of Live 3D TEE on the interatrial septum and/or
ASD and device closure have been reported recently
[128—130]. Based on one of these recent studies,
conventional 2D TEE measurements of ASD were
larger than those determined by live/real-time TEE
3D in patients with large ASD. 3D TEE showed
greater values of the maximal ASD size than 2D echo
because 3D echo can visualize the entire shape of
ASD clearly while 2D echo could not. No one can
deny this clear advantage of 3D echocardiographyT. Shiota
Fig. 16) over conventional 2D echocardiography
or the accurate measurement of the size of ASD.
ive/real-time TEE 3D echocardiography was also
ble to conﬁrm the successful closure of ASD in
his study, demonstrating the clinical feasibility of
his new echo method. When considering percu-
aneous closure of ASD, it is critical to know the
ocation, size, and dynamic motion of the ASD rela-
ive to other cardiac structures such as the coronary
inus, inferior vena cava, superior vena cava, and
he aorta.
As for ventricular septal defect (VSD), the older
ype of volume-rendered 3D echocardiography pro-
ided excellent visualization of experimentally
reated defects in 25 patients with VSD [120]. From
n LV en face projection, the positions, sizes, and
hapes of VSDs can be accurately determined. Thus,
he authors predicted that precise imaging by 3D
chocardiographymay be beneﬁcial for surgical and
atheter-based closure of difﬁcult perimembra-
ous and singular or multiple muscular VSDs [120].
eal-time transthoracic 3D echocardiography was
uccessfully used to evaluate various congenital
eart diseases [125,127]. Seventy ﬁve patients with
uspected congenital heart defects were examined
ith the use of real-time transthoracic 3D echocar-
iography [122]. Less than 5min were needed to
cquire real-time 3D echocardiographic images in
ll cases, and sedation was never required. Real-
ime 3D echocardiography identiﬁed all structural
bnormalities except for small ASD in 2 patients
nd coronary artery anatomy in D-transposition of
he great arteries. The investigators concluded that
nique region-oriented views obtained from the
D data set could be acquired quickly and have
he potential to enhance understanding of complex
ardiac anatomy [122]. Considering the higher qual-
ty of imaging of real-time 3D TEE, this method
s surely promising to obtain detailed anatomi-
al information for complicated congenital heart
bnormalities.
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